Document is current

Any future updates will be listed below

A meta-analysis and systematic review of the first Trop-2-targeting antibody–drug conjugate (sacituzumab govitecan) in treating metastatic breast cancer

Crossref DOI link: https://doi.org/10.1007/s00228-025-03876-w

Published Online: 2025-07-07

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark